Torben Plesner
University of Southern Denmark(DK)Vejle Sygehus(DK)Region of Southern Denmark(DK)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Peptidase Inhibition and Analysis, Chronic Lymphocytic Leukemia Research, Protein Degradation and Inhibitors, Cancer Treatment and Pharmacology
Most-Cited Works
- → Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma(2016)1,421 cited
- → Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma(2015)1,106 cited
- → Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma(2019)969 cited
- → Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma(2016)900 cited
- → Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma(2012)737 cited
- → First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial(2016)617 cited